Cerebrovascular Stroke Clinical Trial
Official title:
Sub-Acute Stroke Rehabilitation With Assisted Movement With Enhanced Sensation
The AMES device is designed to produce functional cortical changes by:(1) assisting the subject as he/she attempts to move the limb (assisted movement) and (2) enhancing movement sensation by vibrating the muscles during movement (enhanced sensation). The primary hypothesis is that the combination of assisted movement and enhanced sensation from muscle vibration can increase the amount of motor recovery in individuals disabled by a stroke.
Approximately 700,000 U.S. citizens have a stroke each year with about half ending up with significant motor disabilities. There are an estimated 5 million stroke survivors in the U.S., making strokes the leading cause of long-term disability in the U.S.. Existing rehabilitation therapies have not been effective in returning all stroke survivors to full motor recovery. The AMES device was designed to be able to provide therapy for the hand (fingers/wrist). In this 18 treatment sessions, double-blinded, control study, AMES therapy will be provided in addition to the usual physician-ordered rehabilitation during the sub-acute period following a stroke. Those control subject who complete the Phase 1 placebo sessions will have the opportunity to cross-over to participate in a AMES treatment group for a Phase 2. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
Completed |
NCT02478177 -
Addressing Real-world Anticoagulant Management Issues in Stroke
|
||
Not yet recruiting |
NCT04378946 -
Error Augmentation Motor Learning Training Approach in Stroke Patients
|
N/A | |
Completed |
NCT04103034 -
A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
|
Phase 1 | |
Completed |
NCT02207023 -
Healthy Lifestyles After Stroke - Stroke Coach
|
N/A | |
Completed |
NCT03417349 -
Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke
|
||
Recruiting |
NCT02587949 -
The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.
|
||
Completed |
NCT02759627 -
Does Isolated Robotic-Assisted Gait Training Improve Functional Status, Daily Living And Quality Of Life In Stroke?
|
N/A | |
Completed |
NCT02735148 -
The Effects of Body Weight Supported Treadmill Training On Balance In Stroke Patients
|
N/A | |
Terminated |
NCT02465034 -
Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke
|
N/A | |
Completed |
NCT01133106 -
Living Well With Stroke
|
N/A | |
Completed |
NCT00061022 -
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
|
Phase 3 | |
Completed |
NCT02725944 -
Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and TIA
|
||
Not yet recruiting |
NCT04870684 -
Thromboelastometry and Ischemic Stroke (ThromboPredict)
|
||
Terminated |
NCT03094715 -
Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window
|
N/A | |
Completed |
NCT05013762 -
Fast Arm Motor Skill Training
|
N/A | |
Not yet recruiting |
NCT01205490 -
Changes in Cerebral Blood Flow With Spinal Manipulative Therapy vs. Voluntary Motion
|
N/A | |
Recruiting |
NCT01144650 -
Dapsone for Acute Ischemia Stroke Study
|
Phase 2/Phase 3 | |
Completed |
NCT00608582 -
Transcranial Magnetic Stimulation to Improve Speech in Aphasia
|
Phase 2 | |
Not yet recruiting |
NCT05920291 -
Carotid Doppler Findings of High Risk Group of Stroke
|